AyurMaya led a $45m Series C round in Koneksa.

AyurMaya, an affiliated fund of Matrix Capital Management, led a $45m Series C funding round in Koneksa, a digital biomarkers maker, with participation from Takeda Ventures, Velosity Capital. McKesson Ventures, Merck Global Health Innovation Fund, Novartis (dRx Capital), Spring Mountain Capital and Waterline Ventures. “We contribute to better lives by building health measurements that matter. I’m delighted to welcome John Wagner, one of our earliest collaborators and an industry pioneer to our leadership team. We look forward to accelerating development of our biomarker technology platform and expanding our team to deliver more efficient clinical trials," Chris Benko, Koneksa CEO.